Could a breast cancer drug shrink pancreatic cysts and spare patients from surgery?
NCT ID NCT06320990
First seen May 14, 2026 · Last updated May 14, 2026
Summary
This early study tests whether tamoxifen, a drug used for breast cancer, can shrink or stabilize pancreatic cysts that may turn into cancer. Up to 15 women with these cysts who are not having surgery right away will take tamoxifen daily for up to 24 weeks. The main goal is to see if patients can stick with the treatment and if the cysts get smaller.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CYST are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Nebraska Medical Center
RECRUITINGOmaha, Nebraska, 68198, United States
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.